Lobaplatin in advanced urothelial tract tumors

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days

Elisabeth G.E. de Vries, Phb Willemse, Henk‐Jan Guchelaar et al. · British Journal of Cancer · 1993 · 55 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +4

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines

A. Harstrick, Carsten Bokemeyer, Martin Scharnofkse et al. · Cancer Chemotherapy and Pharmacology · 1993 · 53 citations

-Resistant Human Testicular, Malignant Disease, Oncogenic Agent +11

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer

G.J. Veldhuis, Henk‐Jan Guchelaar, Phb Willemse et al. · British Journal of Cancer · 1995 · 52 citations · Full text

Medicine, Pharmacology, Pharmacokinetic Study +8

A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion

Jourik A. Gietema, Henk‐Jan Guchelaar, Elisabeth G.E. de Vries et al. · Anti-Cancer Drugs · 1993 · 32 citations

Phase I Clinical Trial of Lobaplatin (D-19466) after Intravenous Bolus Injection

H.H. Fiebig, H. Henß, K. Mross et al. · Oncology Research and Treatment · 1994 · 18 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +12